Paller, A., Siegfried, E., Simpson, E., Cork, M., Lockshin, B., Kosloski, M., . . . Bansal, A. (2020). A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: Pharmacokinetics, safety and efficacy. J Eur Acad Dermatol Venereol.
Chicago-tyylinen lähdeviittausPaller, A.S., et al. "A Phase 2, Open‐label Study of Single‐dose Dupilumab in Children Aged 6 months to <6 years With Severe Uncontrolled Atopic Dermatitis: Pharmacokinetics, Safety and Efficacy." J Eur Acad Dermatol Venereol 2020.
MLA-viitePaller, A.S., et al. "A Phase 2, Open‐label Study of Single‐dose Dupilumab in Children Aged 6 months to <6 years With Severe Uncontrolled Atopic Dermatitis: Pharmacokinetics, Safety and Efficacy." J Eur Acad Dermatol Venereol 2020.